PANACEABIO
BiotechnologyPANACEA BIOTEC LTD.
NSE: PANACEABIOBSE: 531349ISIN: INE922B01023
₹494.00
-54.85 · -9.99%
As of 21 Jul 2026
Open
₹551.95
High
₹560.95
Low
₹494.00
Prev Close
₹548.85
52W High
₹647.00
52W Low
₹292.40
Volume
6.61 L
Mkt Cap
₹3,019 Cr
Fundamentals
Valuation & profitability
Market Cap
₹3,019 Cr
P/E Ratio
0
EPS (TTM)
₹-14.28
Book Value
₹137.00
Dividend Yield
0%
ROCE
3.6%
ROE
4.1%
Sales Growth
-4%
Face Value
₹1.00
Key highlights
Auto-generated from live data
- Trades at a P/E of 0, with a return on equity (ROE) of 4.1%.
- PANACEABIO is trading above 2 of 5 of its key moving averages (10/20/50/100/200-DMA) — a bearish technical setup.
- Year-to-date it is up 46.61%, and up 36.82% over the past year.
- At ₹494.00 it sits about 57% of the way up its 52-week range (₹292.40–₹647.00).
- Market capitalisation stands at ₹3,019 Cr.
Price chart
Daily candles + volume · SMA 20 / 50 / 200 · stored OHLC
Shareholding pattern
Shareholding data syncs daily.
Performance
Stock returns vs Nifty 50
10D
+3.56%
Nifty +0.99%
20D
+1.64%
Nifty +1.44%
50D
+38.95%
Nifty +3.77%
100D
+74.79%
Nifty +2.90%
200D
+47.72%
Nifty -7.20%
YTD
+46.61%
Nifty -7.18%
52W
+36.82%
Nifty -6.08%
Moving averages
Simple moving averages vs current price
SMA 10-Day
₹544.77Below
SMA 20-Day
₹546.75Below
SMA 50-Day
₹495.25Below
SMA 100-Day
₹417.99Above
SMA 200-Day
₹402.52Above
Price ranges
Where the price sits in each window
10-Day range₹494.00
₹520.25₹576.90
20-Day range₹494.00
₹520.25₹597.00
50-Day range₹494.00
₹363.50₹647.00
200-Day range₹494.00
₹292.40₹647.00
YTD range₹494.00
₹292.40₹647.00
52-Week range₹494.00
₹292.40₹647.00
Annual financials
Revenue, profit & EPS by financial year
| Year | Revenue | Net Profit | EPS | NPM |
|---|---|---|---|---|
| Mar 2023 | ₹257 Cr | ₹-88.00 Cr | ₹-14.28 | -34.24% |
| Mar 2022 | ₹236 Cr | ₹-94.00 Cr | ₹-15.27 | -39.83% |
| Mar 2021 | ₹344 Cr | ₹-14.00 Cr | ₹-2.36 | -4.07% |
| Mar 2020 | ₹544 Cr | ₹-194.00 Cr | ₹-31.69 | -35.66% |
| Mar 2020 | ₹544 Cr | ₹-194.00 Cr | ₹-31.69 | -35.66% |
| Mar 2019 | ₹457 Cr | ₹38 Cr | ₹6.16 | 8.32% |
| Mar 2019 | ₹457 Cr | ₹38 Cr | ₹6.16 | 8.32% |
| Mar 2018 | ₹593 Cr | ₹-74.00 Cr | ₹0.00 | -12.48% |
| Mar 2017 | ₹544 Cr | ₹-54.00 Cr | ₹0.00 | -9.93% |
| Mar 2016 | ₹653 Cr | ₹-18.00 Cr | ₹0.00 | -2.76% |
| Mar 2015 | ₹687 Cr | ₹-107.00 Cr | ₹0.00 | -15.57% |
| Mar 2014 | ₹510 Cr | ₹-112.00 Cr | ₹0.00 | -21.96% |
Dividend history
Per share, by ex-date
Ex-Date: 19 Sept 2011₹0.75
Ex-Date: 16 Sept 2010₹0.25
Ex-Date: 19 Sept 2008₹1.00
Ex-Date: 21 Sept 2007₹1.00
Ex-Date: 07 Aug 2001₹10.00
Bulk & block deals
Recent large transactions
| Date | Client | Type | Qty | Price |
|---|---|---|---|---|
| 17 May 2021 | ADAR CYRUS POONAWALLA . | SALE | 31,57,034 | ₹373.85 |
| 17 May 2021 | SERUM INSTITUTE OF INDIA PRIVATE LIMITED | PURCHASE | 31,57,034 | ₹373.85 |
| 17 May 2021 | ADAR CYRUS POONAWALLA . | SALE | 31,57,034 | ₹373.85 |
| 17 May 2021 | SERUM INSTITUTE OF INDIA PRIVATE LIMITED | PURCHASE | 31,57,034 | ₹373.85 |
| 26 Mar 2018 | ADAR CYRUS POONAWALLA | PURCHASE | 31,57,900 | ₹285.00 |
| 26 Mar 2018 | SERUM INSTITUTE OF INDIA LIMITED | SALE | 31,57,900 | ₹285.00 |
| 26 Mar 2018 | ADAR CYRUS POONAWALLA | PURCHASE | 31,57,900 | ₹285.00 |
| 26 Mar 2018 | SERUM INSTITUTE OF INDIA LIMITED | SALE | 31,57,900 | ₹285.00 |
| 14 Oct 2008 | MIRAE ASSET INDIA EQUITY MASTER INV TRUST | SALE | 5,61,778 | ₹220.00 |
| 14 Oct 2008 | SERUM INSTITUTE OF INDIA LTD | PURCHASE | 10,00,416 | ₹220.00 |
| 30 Sept 2008 | SERUM INSTITUTE OF INDIA LTD | PURCHASE | 5,00,657 | ₹222.00 |
| 30 Sept 2008 | THE INDIA FUND INC | SALE | 5,02,512 | ₹222.00 |
Fundamentals, financials & technicals sourced from niftytrader.in, cached and refreshed periodically.